- Home
- / Propanc Biopharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Propanc Biopharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$275.2 K
2024-10-29
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of goods sold | 28.1K | |||||||||||
| General and administrative expense | 11.6M | 1.3M | 2.3M | 3.3M | 1.6M | 1.7M | 1.5M | 1.3M | 57.0M | |||
| Operating expense total | 11.6M | 1.3M | 6.9M | 5.7M | 4.0M | 2.6M | 3.5M | 2.0M | 1.7M | 1.5M | 57.3M | |
| EBIT | (11.6M) | (1.4M) | (6.9M) | (5.7M) | (4.0M) | (2.6M) | (3.5M) | (1.8M) | (2.0M) | (1.8M) | (1.5M) | (57.3M) |
| Interest income | 141.0 | 2.0K | 685.0 | 87.0 | 31.0 | 946.0 | 1.0 | 5.6K | 36.0 | 60.0 | 9.0 | |
| Interest expense | 3.0K | 4.5M | 3.2M | 2.8M | 568.8K | 532.8K | 9.5K | |||||
| Pre tax profit | (11.6M) | (1.5M) | (9.5M) | (8.2M) | (5.8M) | (4.9M) | (2.1M) | (2.7M) | (2.8M) | (1.9M) | (58.9M) | |
| Income tax expense | (173.9K) | (60.5K) | (72.5K) | (305.7K) | (115.4K) | (134.7K) | (113.4K) | (55.0K) | (129.8K) | (129.1K) | ||
| Net Income | (11.4M) | (1.4M) | (9.4M) | (7.9M) | (7.0M) | (5.8M) | (4.7M) | (2.0M) | (2.7M) | (2.7M) | (1.8M) | (58.9M) |
| EPS | (1.8) | 0.0 | (14.8) |